With a revenue increase of 7.75% in the second quarter 2026, year on year to cumulative value of $231 million, Puma Biotechnology Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,291,866, this is below the company average.
Within the Healthcare sector Employees of 64 other companies have achieved higher revenue per employee. While Puma Biotechnology Inc 's total ranking has deteriorated compared to the previous quarter from 482 to 698. Puma Biotechnology Inc has 179 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PBYI Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	7.75 %	-2.59 %	27.72 %	-32.36 %	11.37 %
Sales per Employee (TTM) $	1,291,866	1,269,151	1,275,816	1,184,330	1,329,955
PBYI's Total Ranking	# 698	# 482	# 1348	# 1339	# 1176
Seq. Revenue Change	26.08 %	-40.61 %	38.51 %	3.89 %	13.97 %

PBYI Company Profile >> Back to PBYI Efficiency Comparisons >> Compare PBYI Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 42
Healthcare Sector	# 65
Overall Market	# 698

Revenue per Employee Statistics
High	Average	Low
$ 1,601,642	$ 1,311,926	$ 809,877
(Jun 30 2019)		(Jun 30 2018)

Financial Statements
Puma Biotechnology Inc 's Revenue MRQ	$ 57 Millions	Visit PBYI's Income Statement
Puma Biotechnology Inc 's Revenues TTM	$ 231 Millions	Visit PBYI's aggregate revenue growth
What are PBYI's Sales?		Visit PBYI's Sales by Segment

Other Ratios
Puma Biotechnology Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PBYI's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PBYI's Competitors
Revenue per Employee for PBYI's Suppliers
Revenue per Employee for PBYI's Customers

You may also want to know
PBYI's Sales Growth Rates	PBYI's Pe Price to earnings ratio	PBYI's Receivables Turnover Ratio	PBYI's Stock Quote
PBYI's Net Income Growth Rates	PBYI's Ps Price to Sales ratio	PBYI's Sales per Employee	PBYI's Asset Turnover Ratio
PBYI's Net Margin	PBYI's Pb Price to Book ratio	PBYI's Financial Strength Ratios	PBYI's Dividend Payout Ratio

Date modified: 2026-09-08T21:33:08+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Biocryst Pharmaceuticals Inc	2,162,328.74	$ 940.613 Million	435
Elite Pharmaceuticals Inc	2,155,839.86	$ 140.130 Million	65
Protagonist Therapeutics inc	2,136,303.03	$ 281.992 Million	132
Zevra Therapeutics Inc	2,112,377.05	$ 128.855 Million	61
Liquidia Corporation	2,087,532.41	$ 450.907 Million	216
Tg Therapeutics Inc	2,003,849.62	$ 799.536 Million	399
Prestige Consumer Healthcare Inc	1,938,521.05	$ 1,104.957 Million	570
Privia Health Group Inc	1,923,384.18	$ 2,358.069 Million	1,226
Gilead Sciences Inc	1,791,588.24	$ 30,457.000 Million	17,000
Collegium Pharmaceutical Inc	1,777,172.58	$ 751.744 Million	423
Fennec Pharmaceuticals Inc	1,692,028.57	$ 59.221 Million	35
Neurocrine Biosciences Inc	1,686,950.00	$ 3,373.900 Million	2,000
Mirum Pharmaceuticals Inc	1,661,470.43	$ 618.067 Million	372
Tarsus Pharmaceuticals Inc	1,638,732.43	$ 606.331 Million	370
Agenus Inc	1,638,185.19	$ 132.693 Million	81
Xenetic Biosciences Inc	1,630,388.50	$ 3.261 Million	2
Ideaya Biosciences Inc	1,614,668.97	$ 234.127 Million	145
Rigel Pharmaceuticals Inc	1,590,718.39	$ 276.785 Million	174
Progyny Inc	1,531,890.19	$ 1,311.298 Million	856
Acadia Pharmaceuticals Inc	1,426,870.93	$ 1,138.643 Million	798
Arcutis Biotherapeutics Inc	1,310,680.79	$ 463.981 Million	354
Lantheus Holdings Inc	1,303,724.22	$ 1,555.343 Million	1,193
Cue Biopharma Inc	1,298,413.79	$ 37.654 Million	29
Puma Biotechnology Inc	1,291,865.92	$ 231.244 Million	179
Arvinas Inc	1,287,398.37	$ 316.700 Million	246
Travere Therapeutics Inc	1,189,798.79	$ 591.330 Million	497
Heron Therapeutics Inc	1,183,648.44	$ 151.507 Million	128
Journey Medical Corp	1,175,534.48	$ 68.181 Million	58
Theravance Biopharma inc	1,159,011.11	$ 104.311 Million	90
Corcept Therapeutics Inc	1,138,100.00	$ 830.813 Million	730

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.